benefits of glp-1 coverage in corporate wellness Employers Take a Variety Approaches to Employer FAQs on the Rise
Description
GLP-1 medications alter intestinal motility and secretion, causing diarrhea in some users
The findings, published in JAMA, also showed that prescription rates of these medications were low overall.
Recent studies have shown increasing cases involving gastrointestinal problems linked to glucagon-like peptide-1 (GLP-1) receptor agonists.
Here comes the TMI part: After finishing our Emily in Paris binge-a-thon I quickly said goodbye to my Aunt and Uncle so I could run to vomit
Backed by Science
